Candel Therapeutics, Inc. (CADL) › Weighted Average Diluted SharesCandel Therapeutics, Inc. (CADL) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2021-12-31: 18.87M2022-12-31: 28.82M2023-12-31: 28.94M2024-12-31: 31.68M2025-12-31: 52.96M52.96M2021-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3152.96M+67.2%2026-03-12From 2025-01-012024-12-3131.68M+9.5%2026-03-12From 2024-01-012023-12-3128.94M+0.4%2025-03-13From 2023-01-012022-12-3128.82M+52.7%2024-03-28From 2022-01-012021-12-3118.87M—2023-03-30From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)